Skip to main content

Advertisement

Figure 3 | BMC Research Notes

Figure 3

From: Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses

Figure 3

Changes in serum Trx1 levels in patients with breast and lung cancers as a function of the progress of the cancers. The individual mean value (n = 3) was depicted as a scatter dot plot with the median value of each group (horizontal lines) and the interquartile range (vertical lines). Abbreviations: BC, breast cancer patients; LC, lung cancer patients; I, II, III; divided corresponding cancer (grade I, II, and III, respectively).

Back to article page